#Pharmaceuticals

🏢Release 📈 Stocks

FDA Approves New PREVICOX Tablet Formulation for Boehringer Ingelheim

October 7, 2026 (11 days ago)

Boehringer Ingelheim gains FDA clearance for an improved PREVICOX tablet, offering enhanced dosing flexibility and sustainability benefits for the animal health sector.

Boehringer Ingelheim

🌍 AMERICAS Read More →

🏢Release 🌐 Macro — 📊 Neutral

Galien Foundation Hosts 20th Annual Prix Galien Awards in New York

October 7, 2026 (11 days ago)

Global leaders in medicine and industry gather in New York for the 20th Annual Prix Galien Awards, celebrating significant breakthroughs in pharmaceutical…

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

JNJ and LLY Face New Litigation Over Antipsychotic Breast Cancer Risks

October 7, 2026 (11 days ago)

New lawsuits target Johnson & Johnson and Eli Lilly, alleging that antipsychotic medications Risperdal, Invega, and Zyprexa carry undisclosed breast cancer risks,…

JNJ LLY

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Infinitus Launches FieldForce AI Agent to Automate Pharmaceutical Sales

October 7, 2026 (11 days ago)

Infinitus introduces FieldForce, an AI agent platform built to optimize pharmaceutical sales workflows and provider engagement without increasing staffing costs.

Infinitus

🌍 US Read More →

🏢Release 📈 Stocks

LG CNS Targets Pharmaceutical Sector with Manufacturing AX at CPHI Milan 2026

October 7, 2026 (12 days ago)

LG CNS expands its Manufacturing AX footprint into the pharmaceutical sector, highlighting autonomous factory solutions at the upcoming CPHI Milan 2026 exhibition.

LG CNS

🌍 ASIA Read More →

🏢Release 📈 Stocks

Luminous Mind Secures Patent for Non-Hallucinogenic Psychedelic Compounds

October 6, 2026 (12 days ago)

Luminous Mind, Inc. targets a billion-dollar market opportunity after securing a U.S. patent for non-hallucinogenic psychedelic compounds, sparking interest in potential strategic…

LMI

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

SHARx Launches Grassroots Campaign to Address Prescription Drug Affordability

October 6, 2026 (12 days ago)

SHARx introduces the 'Rising Tides' campaign to challenge prescription drug access barriers and promote affordability through a coalition of athletes and community…

SHARx

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Zydus Lifesciences Launches First Generic Adempas in U.S. Market

October 5, 2026 (13 days ago)

Zydus Lifesciences and MSN Laboratories introduce the first generic riociguat to the U.S. market, challenging Bayer's Adempas dominance in the pulmonary hypertension…

ZYDUSLIFE MSN BAYN.DE

🌍 AMERICAS Read More →

🏢Release 📈 Stocks — 📊 Neutral

51% of U.S. Drug Launches Beat Wall Street Revenue Forecasts in 2025

October 5, 2026 (13 days ago)

Trinity Life Sciences reports that 51% of 2025 U.S. drug launches exceeded Wall Street revenue targets, with oncology products leading the sector's…

🌍 AMERICAS Read More →

📰News 📈 Stocks

AstraZeneca Camizestrant Approval Poised to Drive SERD Market Growth

October 5, 2026 (13 days ago)

AstraZeneca's camizestrant approval acts as a catalyst for the expanding SERD market, with growth driven by demographic shifts and advancements in breast…

AZN

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

FDA Approves OMLYCLO as First Interchangeable Biosimilar to XOLAIR

October 5, 2026 (13 days ago)

OMLYCLO secures FDA approval as the first interchangeable biosimilar to XOLAIR, set to be available in multiple dosage strengths to challenge existing…

GSK MRK

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Eli Lilly Reports Positive EBGLYSS Data for Atopic Dermatitis Treatment

October 5, 2026 (13 days ago)

Eli Lilly shares gain as new clinical data for EBGLYSS confirms long-term efficacy and reduced topical treatment needs for patients suffering from…

LLY

🌍 AMERICAS Read More →